Annual CFF:
$809.89M+$755.57M(+1390.92%)Summary
- As of today, DYN annual cash from financing is $809.89 million, with the most recent change of +$755.57 million (+1390.92%) on December 31, 2024.
- During the last 3 years, DYN annual cash from financing has risen by +$652.07 million (+413.17%).
- DYN annual cash from financing is now at all-time high.
Performance
DYN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$217.33M+$116.55M(+115.66%)Summary
- As of today, DYN quarterly cash from financing is $217.33 million, with the most recent change of +$116.55 million (+115.66%) on September 30, 2025.
- Over the past year, DYN quarterly cash from financing has increased by +$199.32 million (+1106.77%).
- DYN quarterly cash from financing is now -46.78% below its all-time high of $408.39 million, reached on March 31, 2024.
Performance
DYN Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$462.98M+$199.32M(+75.60%)Summary
- As of today, DYN TTM cash from financing is $462.98 million, with the most recent change of +$199.32 million (+75.60%) on September 30, 2025.
- Over the past year, DYN TTM cash from financing has dropped by -$343.43 million (-42.59%).
- DYN TTM cash from financing is now -42.83% below its all-time high of $809.89 million, reached on December 31, 2024.
Performance
DYN TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DYN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +1390.9% | +1106.8% | -42.6% |
| 3Y3 Years | +413.2% | +10000.0% | +10000.0% |
| 5Y5 Years | +3951.7% | - | - |
DYN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +2066.1% | -46.8% | >+9999.0% | -42.8% | >+9999.0% |
| 5Y | 5-Year | at high | +3951.7% | -46.8% | +2041.5% | -42.8% | +4235.9% |
| All-Time | All-Time | at high | +6419.8% | -46.8% | +2041.5% | -42.8% | +4235.9% |
DYN Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $217.33M(+115.7%) | $462.98M(+75.6%) |
| Jun 2025 | - | $100.77M(-28.7%) | $263.66M(-51.4%) |
| Mar 2025 | - | $141.24M(+3784.5%) | $542.75M(-33.0%) |
| Dec 2024 | $809.89M(+1390.9%) | $3.64M(-79.8%) | $809.89M(+0.4%) |
| Sep 2024 | - | $18.01M(-95.3%) | $806.41M(+2.2%) |
| Jun 2024 | - | $379.86M(-7.0%) | $788.85M(+81.8%) |
| Mar 2024 | - | $408.39M(>+9900.0%) | $433.89M(+698.7%) |
| Dec 2023 | $54.32M(+45.3%) | $147.00K(-67.6%) | $54.32M(-40.6%) |
| Sep 2023 | - | $454.00K(-98.2%) | $91.38M(+0.4%) |
| Jun 2023 | - | $24.91M(-13.6%) | $90.99M(+37.5%) |
| Mar 2023 | - | $28.82M(-22.5%) | $66.19M(+77.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $37.39M(-76.3%) | $37.20M(>+9900.0%) | $37.39M(>+9900.0%) |
| Sep 2022 | - | $70.00K(-29.3%) | $276.00K(-58.4%) |
| Jun 2022 | - | $99.00K(+450.0%) | $663.00K(+12.6%) |
| Mar 2022 | - | $18.00K(-79.8%) | $589.00K(-99.6%) |
| Dec 2021 | $157.82M(-58.5%) | $89.00K(-80.5%) | $157.82M(+7.7%) |
| Sep 2021 | - | $457.00K(+1728.0%) | $146.54M(+0.3%) |
| Jun 2021 | - | $25.00K(-100.0%) | $146.08M(+0.0%) |
| Mar 2021 | - | $157.25M(+1504.8%) | $146.06M(+1404.8%) |
| Dec 2020 | $380.69M(+1804.5%) | -$11.19M(>-9900.0%) | -$11.19M(>-9900.0%) |
| Dec 2019 | $19.99M(+60.9%) | $0.00 | $0.00 |
| Dec 2018 | $12.42M | - | - |
FAQ
- What is Dyne Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Dyne Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Dyne Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of DYN is $809.89M
What is the all-time high annual cash from financing for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual cash from financing is $809.89M
What is Dyne Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, DYN annual cash from financing has changed by +$755.57M (+1390.92%)
What is Dyne Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of DYN is $217.33M
What is the all-time high quarterly cash from financing for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly cash from financing is $408.39M
What is Dyne Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, DYN quarterly cash from financing has changed by +$199.32M (+1106.77%)
What is Dyne Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of DYN is $462.98M
What is the all-time high TTM cash from financing for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high TTM cash from financing is $809.89M
What is Dyne Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, DYN TTM cash from financing has changed by -$343.43M (-42.59%)